BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY:HE@Cam seminar: Mark Connolly - The public economics consequences 
 of health and investments in healthcare - Mark Connolly
DTSTART:20180416T140000Z
DTEND:20180416T150000Z
UID:TALK102829@talks.cam.ac.uk
CONTACT:Patricia Peinado - Assistant Professor
DESCRIPTION:Health Economics @ Cambridge welcomes Mark Connolly for the se
 minar: The public economics consequences of health and investments in heal
 thcare: A government perspective framework. During the seminar\, Mark will
  present his work on how to estimate wider costs to Governments arising fr
 om ill health.\n\n*Time:* 15:00-16:00\, Monday 16th April 2018\n*Venue:* L
 arge Seminar Room\, 1st Floor\, Institute of Public Health\, University Fo
 rvie Site\, Robinson Way\, Cambridge\n\nInformation can also be found at "
 HE@Cam's website":http://www.publichealth.cam.ac.uk/16-april-2018-mark-con
 nolly-public-economics-consequences-health-investments-healthcare/\n\n*Abo
 ut the seminar:*\nChanges in health status have economic costs that can ex
 tend beyond the health service. Previous studies have indicated that poor 
 health in working aged adults\, and similarly with children who represent 
 future workers\, represent the major costs of ill-health to government. Fo
 r example\, a study by the UK government reported non-health costs £62-76
  billion annually (2007) of which £29 billion was workless benefits and 
 £28-36 billion in lost tax revenue from poor health. The health sector co
 sts included in typical NICE type cost-effectiveness analysis represented 
 only 8-15% of total government costs. These figures suggest a “governmen
 t perspective” framework that accounts for transfer costs and lost tax r
 evenues might be more suitable for informing the benefits of healthcare in
  tax finance public health systems. To address the value of health and hea
 lthcare investments for government\, we have developed a fiscal health ana
 lytic framework that captures how changes in morbidity and mortality influ
 ence tax revenue and transfer costs (e.g. disability\, allowances\, ongoin
 g health costs). The framework can be used to evaluate the marginal impact
  of discrete investments in healthcare or a mix of interventions to inform
  governmental budgetary consequences. In this context\, the framework can 
 be considered as a fiscal budget impact\, and/or cost-benefit analysis mod
 el that accounts for how morbidity and mortality linked to specific progra
 ms represent both ongoing costs and tax revenue for government. Several ex
 amples applying the public economic impact of vaccines\, women’s health\
 , and behavioral disorders will be discussed. Applications of the fiscal m
 odelling approach will be discussed and implications for allocation decisi
 ons based on public economic consequences and priority setting will be dis
 cussed.\n\n*Mark Connolly:*\nMark is the Managing Director at Global Marke
 t Access Solutions\, with more than 18 years of commercial experience in p
 roduct reimbursement\, technology assessment\, market access and pricing. 
 Prior to founding GMAS\, Mark held pharmaceutical positions in Australia\,
  and global positions in UK and Switzerland. Mark holds a guest lecturer p
 osition at the Pharmacoepidemiology and Pharmacoeconomics Department of th
 e University of Groningen in the Netherlands. He has published over 30 pee
 r-reviewed articles and has had his work reported in major print\, televis
 ion and internet media\, including the BBC\, Newsweek and the Economist.\n
 \n*All welcome. Part of the HE@Cam 2017-18 series.*\nFor any questions\, p
 lease contact: healtheconomics@medschl.cam.ac.uk
LOCATION:Large Seminar Room\, 1st Floor\, Institute of Public Health\, Uni
 versity Forvie Site\, Robinson Way\, Cambridge
END:VEVENT
END:VCALENDAR